GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models

Immunologically cold tumours don’t respond to immune checkpoint blockade inhibition due to poor recruitment of anti-tumour T cells. Authors show here that melanoma-associated lymphatic endothelial cells express G Protein-Coupled Receptor 182 that scavenges CXCL9 and other chemokines necessary for T...

Full description

Bibliographic Details
Published in:Nature Communications
Main Authors: Robert J. Torphy, Yi Sun, Ronggui Lin, Alayna Caffrey-Carr, Yuki Fujiwara, Felix Ho, Emily N. Miller, Martin D. McCarter, Traci R. Lyons, Richard D. Schulick, Ross M. Kedl, Yuwen Zhu
Format: Article
Language:English
Published: Nature Portfolio 2022-01-01
Online Access:https://doi.org/10.1038/s41467-021-27658-x
Description
Summary:Immunologically cold tumours don’t respond to immune checkpoint blockade inhibition due to poor recruitment of anti-tumour T cells. Authors show here that melanoma-associated lymphatic endothelial cells express G Protein-Coupled Receptor 182 that scavenges CXCL9 and other chemokines necessary for T cell recruitment.
ISSN:2041-1723